Figures computed from official regulatory filings — .
Analysttarget 9.25 USD (+438%) · consensus 4.75/5 · 4 buy · 0 hold · 0 sell
Ownershipinsiders 19.52% · institutions 12.83% · short 1.6% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Sintx Technologies, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
55 buys3 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Elmore Robert Ryan | Award | $14.2K | SEC |
| Elmore Robert Ryan | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lyons Christopher Michael | Buy | $21.8K | conv 78Cluster | SEC |
| Lyons Christopher Michael | Buy | $2.2K | conv 78ClusterFirst in 12mo | SEC |
| MOYES JAY M | Buy | $2.9K | conv 69Cluster | SEC |
| Anderson Mark Lewis | Buy | $9.1K | conv 57 | SEC |
| Olson Eric K.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Trask Kevin | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Honigblum Gregg R.track record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Honigblum Gregg R.track record | Buy | $21.2K | conv 45 | SEC |
| Honigblum Gregg R.track record | Buy | $13.7K | conv 30Unusual size | SEC |
| Honigblum Gregg R.track record | Buy | $19.6K | conv 39 | SEC |
| Honigblum Gregg R.track record | Buy | $19.3K | conv 39 | SEC |
| Honigblum Gregg R.track record | Buy | $19.4K | conv 39 | SEC |
| Honigblum Gregg R.track record | Buy | $20.4K | conv 41 | SEC |
| Honigblum Gregg R.track record | Buy | $19.7K | conv 40 | SEC |
| Honigblum Gregg R.track record | Buy | $20K | conv 40 | SEC |
| Honigblum Gregg R.track record | Buy | $19.6K | conv 39 | SEC |
| Honigblum Gregg R.track record | Buy | $19.8K | conv 40 | SEC |
| Honigblum Gregg R.track record | Buy | $20.1K | conv 40 | SEC |
| Honigblum Gregg R.track record | Buy | $18.9K | conv 38 | SEC |
| Honigblum Gregg R.track record | Buy | $19.7K | conv 40 | SEC |
| Honigblum Gregg R.track record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Honigblum Gregg R.track record | Buy | $19.6K | conv 40 | SEC |
| Honigblum Gregg R.track record | Buy | $19.6K | conv 39 | SEC |